Is dementia on the decline? Research suggests it might be

by Allie Shah, Star Tribune (Minneapolis)Despite fears that the coming silver tsunami will trigger a dementia epidemic, a surprising new study suggests that it may be possible to delay - or even preve

Updated on: February 28,2024

Is dementia on the decline? Research suggests it might be

by Allie Shah, Star Tribune (Minneapolis)Despite fears that the coming silver tsunami will trigger a dementia epidemic, a surprising new study suggests that it may be possible to delay - or even preve

Updated on:February 28,2024

Transcranial direct current stimulation found to be safe, effective for tardive dyskinesia

by Lori SolomonTranscranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically hospitalized

Updated on: November 27,2024

Transcranial direct current stimulation found to be safe, effective for tardive dyskinesia

by Lori SolomonTranscranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically hospitalized

Updated on:November 27,2024

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim

Updated on: February 28,2024

Early abnormalities of Alzheimer's disease: It takes two (proteins) to tango

by McGill UniversityCredit: McGill UniversityFor years, neuroscientists have puzzled over how two abnormal proteins, called amyloid and tau, accumulate in the brain and damage it to cause Alzheim

Updated on:February 28,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on: April 16,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on:April 16,2024

New insights into Niemann-Pick type C: A form of childhood dementia

by Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)Bone marrow-derived macrophages (BMDMs) share key molecular and functional alterations observed in NPC1-deficient microglia. Credit:&

Updated on: December 17,2024

New insights into Niemann-Pick type C: A form of childhood dementia

by Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)Bone marrow-derived macrophages (BMDMs) share key molecular and functional alterations observed in NPC1-deficient microglia. Credit:&

Updated on:December 17,2024

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on: March 07,2024

Pimavanserin reduced symptoms of dementia-related psychosis in phase 3 trial

by University of ExeterA large-scale trial has found a treatment with pimavanserin substantially reduced psychotic symptoms and reduced risk of relapse of those symptoms compared to placebo in pe

Updated on:March 07,2024

Brain exercise and training program to improve mind and body wellness in individuals with mild cognitive impairment

by Courtney Caprara,University of PittsburghIndividuals with mild cognitive impairment have a new resource in Pittsburgh with the recently establishedBrain Training and Exercise(BRiT

Updated on: March 07,2024

Brain exercise and training program to improve mind and body wellness in individuals with mild cognitive impairment

by Courtney Caprara,University of PittsburghIndividuals with mild cognitive impairment have a new resource in Pittsburgh with the recently establishedBrain Training and Exercise(BRiT

Updated on:March 07,2024

Precise map of primate foveolar cortex uncovers intricacies of brain's visual system

by Ingrid Fadelli , Medical XpressColor-coded responses to different visual stimuli. a, Activations to achromatic high-SF gratings (in cycles per degree). Yellow, SF11; purple, SF15; orange, SF18. b,

Updated on: January 14,2025

Precise map of primate foveolar cortex uncovers intricacies of brain's visual system

by Ingrid Fadelli , Medical XpressColor-coded responses to different visual stimuli. a, Activations to achromatic high-SF gratings (in cycles per degree). Yellow, SF11; purple, SF15; orange, SF18. b,

Updated on:January 14,2025

MouseGoggles offer immersive look into neural activity

MouseGoggles offer immersive look into neural activityby David Nutt,Cornell UniversityCornell researchers built miniature VR headsets to immerse mice more deeply in virtual environments that can

Updated on: January 18,2025

MouseGoggles offer immersive look into neural activity

MouseGoggles offer immersive look into neural activityby David Nutt,Cornell UniversityCornell researchers built miniature VR headsets to immerse mice more deeply in virtual environments that can

Updated on:January 18,2025

New brain discovery could help in the fight against obesity

byUniversity of AberdeenCredit:Current Biology(2024). DOI: 10.1016/j.cub.2024.02.074One of the largest threats to human health is obesity, but now researchers from the University of

Updated on: March 28,2024

New brain discovery could help in the fight against obesity

byUniversity of AberdeenCredit:Current Biology(2024). DOI: 10.1016/j.cub.2024.02.074One of the largest threats to human health is obesity, but now researchers from the University of

Updated on:March 28,2024

Alzheimer's disease: Five things to know

Credit: Unsplash/CC0 Public DomainAlzheimer's disease, a devastating neuro-degenerative condition that causes dementia, affects more than 30 million people worldwide and remains an illness for whi

Updated on: March 26,2024

Alzheimer's disease: Five things to know

Credit: Unsplash/CC0 Public DomainAlzheimer's disease, a devastating neuro-degenerative condition that causes dementia, affects more than 30 million people worldwide and remains an illness for whi

Updated on:March 26,2024

FDA head calls for inquiry into Alzheimer's drug review

by Matthew PerroneThis image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. On Friday, July 9, 2021, the acting head of the U.S. Food and Drug Administrati

Updated on: March 30,2024

FDA head calls for inquiry into Alzheimer's drug review

by Matthew PerroneThis image provided by Biogen on Monday, June 7, 2021 shows a vial and packaging for the drug Aduhelm. On Friday, July 9, 2021, the acting head of the U.S. Food and Drug Administrati

Updated on:March 30,2024